Hjem › Prostatakreft › Minnesota › Rochester
Kliniske studier for Prostatakreft i Rochester, MN
22 studier for Prostatakreft søker deltakere på steder i og rundt Rochester (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
RekruttererFase 3
- Research Site, Rochester
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
RekruttererFase 1/2
- GSK Investigational Site, Rochester
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruttererFase 3
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Rekrutterer
- Mayo Clinic, Rochester
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RekruttererFase 3
- Mayo Clinic- Rochester, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mayo Clinic, Rochester
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekruttererFase 1
- Mayo Clinic, Rochester
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Rekrutterer
- Mayo Clinic in Rochester, Rochester
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Rekrutterer
- Mayo Clinic in Rochester, Rochester
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- Mayo Clinic, Rochester
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
RekruttererFrivillige helsepersonell ønskes velkommen
- Mayo Clinic in Rochester, Rochester
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RekruttererFase 4
- Mayo Clinic Rochester, Rochester
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruttererFase 1
- Research Site, Rochester
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- Mayo Clinic, Rochester
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mayo Clinic, Rochester
Understanding of Genetics by Men at Risk for Prostate Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #14, Rochester
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Rochester
- Brystkreft42 studier
- Ikke-småcellet lungekreft37 studier
- Metastatisk kreft31 studier
- Kreft (alle typer)30 studier
- Kolorektal kreft29 studier
- Eggstokkreft29 studier
- Multipelt myelom24 studier
- Hjertesvikt22 studier
- Pankreaskreft22 studier
- Lungekreft20 studier
- Endometriekreft20 studier
- Kronisk lymfatisk leukemi19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.